Three kinships with ALAS2 P520L (c. 1559 C → T) mutation, two in association with severe iron overload, and one with sideroblastic anemia and severe iron overload
Mutations in aminolevulinate synthase 2 ( ALAS2) are usually associated with sideroblastic anemia and iron overload. The objective of this study was to determine if “mild” mutations in ALAS2 might increase the severity of primary iron overload. Direct sequencing of the ALAS2 gene was performed on 24...
Saved in:
Published in | Blood cells, molecules, & diseases Vol. 36; no. 2; pp. 292 - 297 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.03.2006
|
Subjects | |
Online Access | Get full text |
ISSN | 1079-9796 1096-0961 |
DOI | 10.1016/j.bcmd.2005.12.004 |
Cover
Summary: | Mutations in aminolevulinate synthase 2 (
ALAS2) are usually associated with sideroblastic anemia and iron overload. The objective of this study was to determine if “mild” mutations in
ALAS2 might increase the severity of primary iron overload. Direct sequencing of the
ALAS2 gene was performed on 24 subjects with primary hemochromatosis and one subject with sideroblastic anemia with severe iron overload. We identified a novel mutation P520L (c. 1559 C → T) in
ALAS2 in three subjects. Two had severe iron overload and no anemia: one also had
HFE C282Y homozygosity, and the other was wildtype for
HFE and other iron-related genes. The third subject had sideroblastic anemia with iron overload, and was hemizygous for both P520L and R560H (c. 1679 G → A) mutations in
ALAS2. The P520L mutation was found at a frequency of 0.0013 (741 alleles) in white control subjects, but was not found in 158 alleles from black control subjects. The proline in this position is highly conserved across species from humans to zebrafish. However, genotype/phenotype studies of the families demonstrate that the P520L mutation alone has no iron-associated phenotype, but it may act as a modifier of iron overload in the presence of mutations in
HFE or other uncharacterized hemochromatosis genes. Thus,
ALAS2 mutations might contribute to more severe iron loading in persons with primary hemochromatosis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1079-9796 1096-0961 |
DOI: | 10.1016/j.bcmd.2005.12.004 |